CCL3 and myeloid sarcoma: Thus, one explanation for reduced expression of IFNG, CCL3, CLL4, and GZMB in TH1/17 cells in MS could be that migration of cells to the CNS removes CXCR3 high, active TH1/17 cells from the blood.